The promise of NK cells and 3 strategies for creating a cost-effective program

Overview

Interest is growing for natural killer T cell (NK cell)-based therapies for treating various diseases, including cancer and infectious diseases. NK cells have their ability to recognize and kill abnormal cells without prior sensitization, and the potential to enhance the efficacy of existing therapies. Download this industry analysis to learn about how to create a cost-effective NK cell program.

Key Takeaways

• What NK cells offer to the future of biopharma research

• 3 strategies for companies seeking to create NK cell-based treatments